Cargando…
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
SIMPLE SUMMARY: Prostate cancer is the most prevalent male cancer. It poses a survival risk if it spreads and fails treatment. In search of fresh insight into lethal prostate cancers, we examined failures in cancer defence systems operated by the key anticancer protein p53. Normally, levels of p53 a...
Autores principales: | Mejía-Hernández, Javier Octavio, Raghu, Dinesh, Caramia, Franco, Clemons, Nicholas, Fujihara, Kenji, Riseborough, Thomas, Teunisse, Amina, Jochemsen, Aart G., Abrahmsén, Lars, Blandino, Giovanni, Russo, Andrea, Gamell, Cristina, Fox, Stephen B., Mitchell, Catherine, Takano, Elena A., Byrne, David, Miranda, Panimaya Jeffreena, Saleh, Reem, Thorne, Heather, Sandhu, Shahneen, Williams, Scott G., Keam, Simon P., Haupt, Ygal, Haupt, Sue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405814/ https://www.ncbi.nlm.nih.gov/pubmed/36010941 http://dx.doi.org/10.3390/cancers14163947 |
Ejemplares similares
-
The role of MDM2 and MDM4 in breast cancer development and prevention
por: Haupt, Sue, et al.
Publicado: (2017) -
Regulation of Mutant p53 Protein Expression
por: Vijayakumaran, Reshma, et al.
Publicado: (2015) -
The long and the short of it: the MDM4 tail so far
por: Haupt, Sue, et al.
Publicado: (2019) -
Corrigendum to ‘The long and the short of it: the MDM4 tail so far’
por: Haupt, Sue, et al.
Publicado: (2019) -
E6AP promotes prostate cancer by reducing p27 expression
por: Raghu, Dinesh, et al.
Publicado: (2017)